Kirk R. Schultz

21.7k citations

214 papers · 7.4k indexed · 4 hit papers · h-index 45

Impact in

Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Transplantation top 1%

Papers in

Hematology 154
- Hematopoietic Stem Cell Transplantation 121
- Chronic Myeloid Leukemia Treatments 26
- Acute Myeloid Leukemia Research 24
Transplantation 11

Co-authors: Bruce M. Camitta Michael J. Borowitz Stephanie J. Lee Steven Z. Pavletic Nyla A. Heerema Harland N. Sather Andrew J. Carroll Paul S. Gaynon
Journals: Biology of Blood and Marrow Transplantation (48 papers)Blood (37 papers)Bone Marrow Transplantation (11 papers)Journal of Clinical Oncology (10 papers)Transplantation and Cellular Therapy (10 papers)
Partner nations: Canada United States Germany

In The Last Decade

Kirk R. Schultz

204 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment 2018 · 266 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Bone Marrow Transplantation
2016 Biology of Blood and Marrow Transplantation
2015 Biology of Blood and Marrow Transplantation
2014 Leukemia

Peers

Countries citing papers authored by Kirk R. Schultz

Since Specialization

Citations

This map shows the geographic impact of Kirk R. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk R. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk R. Schultz more than expected).

Fields of papers citing papers by Kirk R. Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk R. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk R. Schultz. The network helps show where Kirk R. Schultz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kirk R. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kirk R. Schultz Line = papers co-authored together Kirk R. Schultz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation Transplantation and Cellular Therapy ·Blachy J. Dávila Saldaña, Kirk R. Schultz, 法子小谷, Deguang Pan, Kristen Beebe, Paul A. Carpenter, Sherwin S. Chan, Sophie Paczesny, Paibel Aguayo‐Hiraldo, Geoff D.E. Cuvelier, Seth J. Rotz, Derek J. Crofton, 和行青木	2025	0
2	Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease Transplantation and Cellular Therapy ·Daniel Wolff, Corey Cutler, FiryalHassan Al-Obaidi, Thomas Jaki, David S. Robertson, Kirk R. Schultz, Stephanie J. Lee, Paul J. Martin, Steven Z. Pavletic	2025	0
3	Expansion and characterization of immune suppressive CD56(bright)Perforin(-) regulatory-like natural killer cells in chronic graft-versus-host disease Cytotherapy ·Ayşe Şule ATEŞ, Claire Pollet, Stephen Aitchison, Силин Никита Сергеевич, Touria Zairp, Ramon I. Klein Geltink, Louise Galbraith, Kirk R. Schultz	2024	3
4	Elevated ADA2 Enzyme Activity at the Onset of Chronic Graft-versus-Host Disease in Children Transplantation and Cellular Therapy ·Emily L. Savage, Bernard Ng, Силин Никита Сергеевич, Amina Kariminia, David A. Cabral, Geoff D.E. Cuvelier, Kirk R. Schultz, Kelly L. Brown	2023	0
5	Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study Transplantation and Cellular Therapy ·Paul A. Carpenter, Hyoung Jin Kang, Keon Hee Yoo, Marco Zecca, Bin Cho, Giovanna Lucchini, Eneida R. Nemecek, Kirk R. Schultz, Polina Stepensky, Sonali Chaudhury, Benjamin Oshrine, Seong Lin Khaw, Andrew C. Harris, Cyril Perrollaz, Amenuvor Edem FORTUNE, S Goncalves, Justin T. Wahlstrom, Lori Styles, Peter J. Shaw, Jean‐Hugues Dalle	2022	18
6	Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD Blood Advances ·Nataliya P. Buxbaum, Gèrard Socié, Geoffrey R. Hill, Kelli P. A. MacDonald, Victor Tkachev, Takanori Teshima, Stephanie J. Lee, Jerome Ritz, Stefanie Sarantopoulos, Leo Luznik, Defu Zeng, Sophie Paczesny, Paul J. Martin, Steven Z. Pavletic, Kirk R. Schultz, Bruce R. Blazar	2022	11
7	Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid- Refractory or Dependent Chronic GVHD – a Multicentre Phase II Clinical Trial (CARE Trial) Transplantation and Cellular Therapy ·Imran Ahmad, Janet J. Bijl, Sabine Ivison, Eshetu G. Atenafu, Tony Panzarella, Raewyn Broady, David Szwajcer, Irwin Walker, Dennis Dong Hwan Kim, Christopher Bredeson, Ronan Foley, Donna E. Hogge, David Allan, Jean‐Sébastien Delisle, Kirk R. Schultz, Donna A. Wall, Megan K. Levings, Denis‐Claude Roy	2021	1
8	Experience with ponatinib in paediatric patients with leukaemia British Journal of Haematology ·Jenna Rossoff, Van Huynh, Rachel E. Rau, Margaret E. Macy, Maria Luisa Sulis, Kirk R. Schultz, Michael J. Burke, Uma H. Athale, Maureen M. O’Brien, John Gregory, Inge M. van der Sluis, Frank G. Keller, C. Michel Zwaan, Meinolf Suttorp, Nobuko Hijiya	2020	20
9	Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group Pediatric Blood & Cancer ·Uma H. Athale, Nobuko Hijiya, Briana C. Patterson, John Bergsagel, Jeffrey R. Andolina, Henrique Bittencourt, Kirk R. Schultz, Michael J. Burke, Michele S. Redell, E. Anders Kolb, Donna L. Johnston	2019	46
10	Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study Biology of Blood and Marrow Transplantation ·Leonie Naeije, Amina Kariminia, Силин Никита Сергеевич, K L Hsueh, Peter Subrt, Boris Kuzeljevic, Michael A. Irvine, Irwin Walker, Kirk R. Schultz	2019	7
11	Generic formulations of imatinib for treatment of Philadelphia chromosome–positive leukemia in pediatric patients Pediatric Blood & Cancer ·Meinolf Suttorp, Markus Metzler, Frédéric Millot, Hiroyuki Shimada, Deepak Bansal, Adalet Meral Güneş, Krzysztof Kałwak, Petr Sedláček, André Baruchel, Andrea Biondi, Nobuko Hijiya, Kirk R. Schultz, Martin Schrappe	2018	10
12	Biomarkers in chronic graft-versus-host disease: quo vadis? Bone Marrow Transplantation ·Daniel Wolff, Hildegard Greinix, S. J. Lee, Ted Gooley, Sophie Paczesny, Steven Z. Pavletic, Frances T. Hakim, Florent Malard, Madan Jagasia, Ánita Lawitschka, John A. Hansen, Dražen Pulanić, Ernst Holler, Anne M. Dickinson, Eva M. Weissinger, Matthias Edinger, Stefanie Sarantopoulos, Kirk R. Schultz	2018	44
13	The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Kenneth R. Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T. Hakim, Madan Jagasia, Daniel H. Fowler, Marcel R.M. van den Brink, John A. Hansen, Robertson Parkman, David B. Miklos, Paul J. Martin, Sophie Paczesny, Georgia B. Vogelsang, Steven Z. Pavletic, Jerome Ritz, Kirk R. Schultz, Bruce R. Blazar Hit paper breakdown →	2016	283
14	National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report PMC ·Sophie Paczesny, Frances T. Hakim, Joseph Pidala, Kenneth R. Cooke, Julia Tait Lathrop, Linda M. Griffith, John A. Hansen, Madan Jagasia, David B. Miklos, Steven Z. Pavletic, Robertson Parkman, Estelle Russek‐Cohen, Mary E.D. Flowers, Stephanie J. Lee, Paul J. Martin, Georgia B. Vogelsang, Marc K. Walton, Kirk R. Schultz	2015	1
15	Tumor Necrosis Factor-α Gene Polymorphisms Are Associated with Severity of Acute Graft-Versus-Host Disease Following Matched Unrelated Donor Bone Marrow Transplantation in Children: A Pediatric Blood and Marrow Transplant Consortium Study Biology of Blood and Marrow Transplantation ·Rakesh K. Goyal, Yan Lin, Kirk R. Schultz, Robert E. Ferrell, Yeonhee Kim, Liane Fairfull, Elayne Livote, Gregory A. Yanik, Mark Atlas	2010	16
16	Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Journal of Clinical Oncology ·Kirk R. Schultz, W. Paul Bowman, Alexander Aledo, William B. Slayton, Harland N. Sather, Meenakshi Devidas, Chenguang Wang, Stella M. Davies, Paul S. Gaynon, Michael E. Trigg, Robert Rutledge, Laura Burden, Liu Changla, Andrew J. Carroll, Nyla A. Heerema, Naomi Winick, Michael J. Borowitz, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta	2009	436
17	Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group Blood ·Hisaki Fujii, Geoff D.E. Cuvelier, Kevin She, 健治吉田, Hiromi Shimizu, Amina Kariminia, Mark Krailo, Zhengjia Chen, 正大金沢, Susan B. Vacek, Frederick D. Goldman, Stephen Grupp, Donna A. Wall, Andrew L. Gilman, Kirk R. Schultz	2007	104
18	Cardiac manifestations of graft-versus-host disease Biology of Blood and Marrow Transplantation ·Andrew L. Gilman, Daniel Dalla Corte, Fred Goldman, Karl Tagányi, Ka Wah Chan, Kirk R. Schultz	2005	2
19	Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood ·A. John Barrett, Olle Ringdén, Mei‐Jie Zhang, Asad Bashey, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Aloïs Gratwohl, Franco Locatelli, Rodrigo Martino, Kirk R. Schultz, Pierre Tiberghien	2000	66
20	ATAXIA AND PARALYSIS ASSOCIATED WITH BOVINE EPHEMERAL FEVER INFECTION Australian Veterinary Journal ·Huo Ren-shuo, Kirk R. Schultz	1977	10

About Kirk R. Schultz

Kirk R. Schultz is a scholar working on Hematology, Transplantation, Immunology, Public Health, Environmental and Occupational Health and Genetics, having authored 214 papers that have together received 7.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (121 papers), Acute Lymphoblastic Leukemia research (80 papers), Immune Cell Function and Interaction (29 papers), Childhood Cancer Survivors' Quality of Life (26 papers), Chronic Myeloid Leukemia Treatments (26 papers), Acute Myeloid Leukemia Research (24 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (20 papers). The work is most often cited by research in Hematology (5.0k citations), Transplantation (358 citations), Genetics (1.1k citations), Public Health, Environmental and Occupational Health (2.6k citations) and Immunology (1.8k citations). Kirk R. Schultz has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Bruce M. Camitta, Michael J. Borowitz, Stephanie J. Lee, Steven Z. Pavletic, Nyla A. Heerema, Harland N. Sather, Andrew J. Carroll, Paul S. Gaynon, Andrew L. Gilman and Stephen P. Hunger. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Bone Marrow Transplantation, Journal of Clinical Oncology and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact